References
- Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007;370:511–520.
- Adamson JW. Iron deficiency and other hypoproliferative anemias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Isselbacher KJ, eds. Harrison’s principles of internal medicine. 16th ed. New York, NY: McGraw-Hill Companies, Inc.; 2005:586–592.
- Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997;277:973–976.
- Marret H, Fauconnier A, Chabbert-Buffet N, Cravello L, Golfier F, Gondry J, Agostini A, et al.; CNGOF Collège National des Gynécologues et Obstétriciens Français. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 2010;152:133–137.
- Vannella L, Aloe Spiriti MA, Cozza G, Tardella L, Monarca B, Cuteri A, Moscarini M, et al. Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia. Aliment Pharmacol Ther 2008;28:422–430.
- Perkins S., In: Lee G, et al, eds. Chapter: Normal blood and bone marrow values in humans. Wintrobe’s clinical hematology. (Vol. 2). 10th ed. Baltimore, MD: Lippincott, Williams & Wilkins; 1998. p. 2738.
- World Health Organization. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva: WHO; 2001.
- Dallman PR, Looker AC, Johnson CL, Carrol M. Influence of age on laboratory criteria for the diagnosis of iron deficiency anemia and iron deficiency in infants and children. In: Hallberg L, ed. Iron nutrition in health and disease. London: John Libbey & Co; 1996:65–74.
- Galan P, Yoon HC, Preziosi P, Viteri F, Valeix P, Fieux B, Briançon S, et al. Determining factors in the iron status of adult women in the SU.VI.MAX study. SUpplementation en VItamines et Minéraux AntioXydants. Eur J Clin Nutr 1998;52:383–388.
- Deloche C, Bastien P, Chadoutaud S, Galan P, Bertrais S, Hercberg S, de Lacharrière O. Low iron stores: a risk factor for excessive hair loss in non-menopausal women. Eur J Dermatol 2007;17:507–512.
- Fleming RE, Bacon BR. Orchestration of iron homeostasis. N Engl J Med 2005;352:1741–1744.
- Rossi E. Hepcidin–the iron regulatory hormone. Clin Biochem Rev 2005;26:47–49.
- Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 2003;102:4191–4197.
- Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World J Gastroenterol 2009;15:4617–4626.
- World Health Organisation. Preventing and controlling iron deficiency anaemia through primary health care. A guide for health administrators and programme managers. Geneva: WHO; 1989.
- Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR 1998;47(No. RR-3):1–36.
- Harju E. Clinical pharmacokinetics of iron preparations. Clin Pharmacokinet 1989;17:69–89.
- Dietzfelbinger H. Bioavailability of bi– and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curves. Arzneimittelforschung 1987;37: 107–112.
- Roetz R. Bioavailability and tolerability criteria of iron therapy. Eisenstoffwechsel – Grundlagen und Probleme. Internationales Tardyferon Symposium, Frankfurt (Main), Germany, 1986.
- Manasanch J, Castelo-Branco C, Cancelo-Hidalgo MJ, et al. Tolerability of different oral iron supplements: a systematic review. Abstract ID 773. 16th WONCA Europe Conference, Málaga, Spaincomment, 6–9 October 2010.